Pregnancy Data Among LNG- and ENG-Releasing Subdermal Implant Users Through 5 Years of Use From Ali et al., 201618
LNG-Releasing Implant | ENG-Releasing Implant | |||||||
---|---|---|---|---|---|---|---|---|
Years 1–3a | Year 4a | Year 5 | Years 1–5 (Cumulative) | Years 1–3a | Year 4a | Year 5 | Years 1–5 (Cumulative) | |
No. of women | 997 | 470 | 330 | 995 | 311 | 204 | ||
Woman-months of observation | 28670 | 6,254 | 4,629 | 30,325 | 28786 | 4,606 | 2,454 | 22,044 |
No. of pregnancies | 3b | 0 | 0 | 3 | 3b | 0 | 0 | 3 |
Cumulative pregnancy rates per 100 woman-yearsc (95% CI) | 0.4 (0.1–1.4) | 0.8 (0.2, 2.3) | 0.4 (0.1–1.4) | 0.6 (0.2, 1.8) |
Abbreviations: CI, confidence interval; ENG, etonogestrel; LNG, levonorgestrel.
↵a Cut-off for 3 years was at 38 months post-insertion while year-4 data started at 36 months post-insertion, resulting in a 2-month overlap in data. Woman-months of observation between these 2 time periods, however, is not additive.
↵b Pregnancy data from the first 3 years reported in Bahamondes et al., 2015.22
↵c Kaplain-Meier rates.